HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of study patients with Lyme disease, 10-20-year follow-up.

Abstract
To determine the long-term impact of Lyme disease, we evaluated 84 randomly selected, original study patients from the Lyme, Connecticut, region who had erythema migrans, facial palsy, or Lyme arthritis 10-20 years ago and 30 uninfected control subjects. The patients in the 3 study groups and the control group did not differ significantly in current symptoms or neuropsychological test results. However, patients with facial palsy, who frequently had more widespread nervous system involvement, more often had residual facial or peripheral nerve deficits. Moreover, patients with facial palsy who did not receive antibiotics for acute neuroborreliosis more often now had joint pain and sleep difficulty and lower scores on the body pain index and standardized physical component sections of the Short-Form 36 Health Assessment Questionnaire than did antibiotic-treated patients with facial palsy. Thus, the overall current health status of each patient group was good, but sequelae were apparent primarily among patients with facial palsy who did not receive antibiotics for acute neuroborreliosis.
AuthorsR A Kalish, R F Kaplan, E Taylor, L Jones-Woodward, K Workman, A C Steere
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 183 Issue 3 Pg. 453-60 (Feb 01 2001) ISSN: 0022-1899 [Print] United States
PMID11133377 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Adult
  • Aged
  • Erythema Chronicum Migrans (complications, physiopathology)
  • Facial Paralysis (etiology, physiopathology)
  • Female
  • Follow-Up Studies
  • Humans
  • Lyme Disease (complications, physiopathology)
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: